{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:36:41Z","timestamp":1747157801839,"version":"3.40.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-breast-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.clbc.2024.03.012","type":"journal-article","created":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T00:20:43Z","timestamp":1711239643000},"page":"e485-e494.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of an Ultrasound-based Nomogram for Predicting Pathologic Complete Response and Axillary Response in Node-Positive Patients with Triple- Negative Breast Cancer"],"prefix":"10.1016","volume":"24","author":[{"given":"Manqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailing","family":"Zha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiazhen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwen","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6909-4357","authenticated-orcid":false,"given":"Yu","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2024.03.012_bib0001","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3322\/caac.21731","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2024.03.012_bib0002","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2024.03.012_bib0003","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrclinonc.2015.63","article-title":"Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy","volume":"12","author":"King","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clbc.2024.03.012_bib0004","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2024.03.012_bib0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer\u2014expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clbc.2024.03.012_bib0006","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1200\/JCO.2005.02.5023","article-title":"Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy","volume":"23","author":"Hennessy","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2024.03.012_bib0007","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1200\/JCO.2002.20.5.1304","article-title":"Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes","volume":"20","author":"Rouzier","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2024.03.012_bib0008","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jamaoncol.2016.4163","article-title":"Axillary nodal management following neoadjuvant chemotherapy: a review","volume":"3","author":"Pilewskie","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2024.03.012_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0891","article-title":"Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis","volume":"156","author":"Samiei","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.clbc.2024.03.012_bib0010","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.2016.71.0947","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"35","author":"Lyman","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2024.03.012_bib0011","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4 suppl","key":"10.1016\/j.clbc.2024.03.012_bib0012","first-page":"GS5","volume":"80","author":"Basik","year":"2020","journal-title":"Cancer Res"},{"issue":"4 Suppl","key":"10.1016\/j.clbc.2024.03.012_bib0013","first-page":"GS5","article-title":"Abstract GS5-06: towards omitting breast surgery in patients with a pathologic complete response after neoadjuvant systemic treatment: interim analysis of the MICRA trial (Minimally Invasive Complete Response Assessment)","volume":"80","author":"TFD","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2024.03.012_bib0014","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/j.jacr.2023.02.016","article-title":"ACR Appropriateness Criteria\u00ae monitoring response to neoadjuvant systemic therapy for breast cancer: 2022 update","volume":"20","author":"Imaging","year":"2023","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.clbc.2024.03.012_bib0015","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s12282-020-01093-0","article-title":"Comparative evaluation of nuclear and histological grades as prognostic factors for invasive breast cancer","volume":"27","author":"Oshiro","year":"2020","journal-title":"Breast Cancer"},{"key":"10.1016\/j.clbc.2024.03.012_bib0016","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2214\/AJR.09.3122","article-title":"Preoperative sonographic classification of ALNs in patients with breast cancer: node-to-node correlation with surgical histology and sentinel node biopsy results","volume":"193","author":"Cho","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clbc.2024.03.012_bib0017","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00330-023-09995-1","article-title":"Ultrasound radiomics-based nomogram to predict lymphovascular invasion in invasive breast cancer: a multicenter, retrospective study","volume":"34","author":"Du","year":"2024","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clbc.2024.03.012_bib0018","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4048\/jbc.2015.18.4.394","article-title":"Histologic grade and decrease in tumor dimensions affect axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients","volume":"8","author":"Kim","year":"2015","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.clbc.2024.03.012_bib0019","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1148\/radiol.2019190014","article-title":"Predicting axillary response to neoadjuvant chemotherapy: breast MRI and US in patients with node-positive breast cancer","volume":"293","author":"Kim","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2024.03.012_bib0020","article-title":"Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis","volume":"375","author":"Conforti","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2024.03.012_bib0021","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jamaoncol.2020.2965","article-title":"Effect of adjuvant paclitaxel and carboplatin on survival in women with triple-negative breast cancer: a phase 3 randomized clinical trial","volume":"6","author":"Yu","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2024.03.012_bib0022","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2019.5410","article-title":"Breast conservation after neoadjuvant chemotherapy for triple-negative breast cancer: surgical results from the brighTNess randomized clinical trial","volume":"155","author":"Golshan","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1016\/j.clbc.2024.03.012_bib0023","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1148\/radiol.2016152331","article-title":"Pretreatment MR imaging features of triple-negative breast cancer: association with response to neoadjuvant chemotherapy and recurrence-free survival","volume":"281","author":"Bae","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2024.03.012_bib0024","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1148\/radiol.2021203871","article-title":"Factors affecting pathologic complete response following neoadjuvant chemotherapy in breast cancer: development and validation of a predictive nomogram","volume":"299","author":"Kim","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2024.03.012_bib0025","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s12282-021-01220-5","article-title":"Accuracy of morphologic change measurements by ultrasound in predicting pathological response to neoadjuvant chemotherapy in triple-negative and HER2-positive breast cancer","volume":"28","author":"Ochi","year":"2021","journal-title":"Breast Cancer"},{"key":"10.1016\/j.clbc.2024.03.012_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109170","article-title":"Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients","volume":"130","author":"Candelaria","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.clbc.2024.03.012_bib0027","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1200\/JCO.2014.57.8401","article-title":"Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American College of Surgeons Oncology Group Z1071 trial (Alliance)","volume":"33","author":"Boughey","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2024.03.012_bib0028","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2214\/AJR.17.18295","article-title":"Axillary ultrasound identifies residual nodal disease after chemotherapy: results from the American College of Surgeons Oncology Group Z1071 trial (Alliance)","volume":"210","author":"Le-Petross","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clbc.2024.03.012_bib0029","doi-asserted-by":"crossref","first-page":"W225","DOI":"10.2214\/AJR.16.17125","article-title":"Predictive clinicopathologic and dynamic contrast-enhanced MRI findings for tumor response to neoadjuvant chemotherapy in triple-negative breast cancer","volume":"208","author":"Eom","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clbc.2024.03.012_bib0030","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Alliance for clinical trials in oncology: sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2024.03.012_bib0031","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1245\/s10434-021-10117-8","article-title":"Prediction of pathologic complete response in breast cancer patients comparing magnetic resonance imaging with ultrasound in neoadjuvant setting","volume":"28","author":"Palshof","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2024.03.012_bib0032","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejca.2021.01.028","article-title":"Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer","volume":"147","author":"Jiang","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2024.03.012_bib0033","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/cncr.34540","article-title":"Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: a multicenter study","volume":"129","author":"Gu","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2024.03.012_bib0034","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s00330-021-08293-y","article-title":"Deep learning radiomics of ultrasonography can predict response to neoadjuvant chemotherapy in breast cancer at an early stage of treatment: a prospective study","volume":"32","author":"Gu","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clbc.2024.03.012_bib0035","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1007\/s00330-020-06662-7","article-title":"Is the presence of edema and necrosis on T2WI pretreatment breast MRI the key to predict pCR of triple negative breast cancer?","volume":"30","author":"Harada","year":"2020","journal-title":"Eur Radiol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924000983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924000983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T10:03:36Z","timestamp":1722074616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820924000983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1526820924000983"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2024.03.012","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an Ultrasound-based Nomogram for Predicting Pathologic Complete Response and Axillary Response in Node-Positive Patients with Triple- Negative Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2024.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}